Pacific Biosciences Improves Key Applications on the Sequel System with New Chemistry and Software Release

Monday, January 9, 2017 MENLO PARK, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system’s ability to support important applications such as structural variant detection and targeted sequencing—including metagenomics, minor... Read more

UPDATE — Pacific Biosciences Improves Key Applications on the Sequel System with New Chemistry and Software Release

MENLO PARK, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system’s ability to support important applications such as structural variant detection and targeted sequencing—including metagenomics, minor variant detection and isoform... Read more

DNAnexus Expands Executive Leadership Team to Drive Commercial Growth Globally

Company CEO to update industry in presentation at the 35th Annual J.P. Morgan Healthcare Conference January 05, 2017 07:30 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus Inc., the global leader in genome informatics and data management, today announced two significant additions to the company’s executive leadership team. Brady Davis has joined the company as... Read more

Edico Genome Offers Bundled Ultra-Rapid Solution for Clinical Genomics and Research

STORY HIGHLIGHTS New Edico Genome bundle offers a pre-configured, out-of-the-box solution for rapid analysis and efficient storage of next-generation sequencing data. Available now, the solution allows for simple implementation for users while reducing storage costs, speeding analysis and maintaining high accuracy. Bundle enables analysis of a whole genome in as little as 22 minutes, which... Read more

GrandOmics Biosciences Expands Investment in PacBio’s Sequel Systems for Precision Medicine Initiative

MENLO PARK, Calif. and BEIJING, Jan. 04, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that GrandOmics Biosciences Co., Ltd of Beijing, through its subsidiary NextOmics in Wuhan, has agreed to purchase five additional Sequel™ instruments to support China’s precision medicine initiative, with a specific focus on ultimately providing the genetic... Read more

Takara Bio USA Holdings, Inc. and Rubicon Genomics Announce Merger Agreement

Takara Bio USA Holdings, Inc. and Rubicon Genomics Announce Merger Agreement Mountain View, CA and Ann Arbor, MI —December 15, 2016—Takara Bio USA Holdings, Inc. (“TBUSH”) and Rubicon Genomics, Inc. (“Rubicon”), today announced the signing of a merger agreement pursuant to which TBUSH will acquire Rubicon, a privately-owned company headquartered in Ann Arbor, Michigan. Rubicon... Read more

QIAGEN Introduces Novel Technology for Customized RNAi Assay Products

VENLO, The Netherlands, November 13 /PRNewswire-FirstCall/ -- - Worldwide First Solution for Flexible siRNA Selection Provides New Dimension of Utility and Performance in one of Life Sciences' Most Promising Disciplines QIAGEN, (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) the world's leading provider of products for pre-analytical sample preparation and a leader in molecular diagnostics, has introduced... Read more